letibotulinumtoxinA (Pending FDA Approval)

Brand and Other Names:
Sections

Dosing & Uses

Glabellar Lines

Pending FDA approval for temporary improvement of moderate-to-severe glabellar lines

Next:

Pharmacology

Mechanism of Action

Neurotoxin from Clostridium botulinum; prevents ACh release from presynaptic membrane, causing temporary calming of muscle contractions by blocking the transmission of nerve impulses

Previous
Next:

Images

No images available for this drug.
Previous
Next:

Patient Handout

A Patient Handout is not currently available for this monograph.
Previous
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.